Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer
Setsuko K. Chambers(University of Arizona), David S. Alberts(University of Arizona), Haiyan Cui(Tongji University), Nisreen Abu Shahin(University of Arizona), Cynthia Laughren(University of Arizona), Mary C. Clouser(University of Arizona), Heather Wright(University of Arizona), Kenneth D. Hatch(Banner - University Medical Center Tucson), Mike F. Janicek(University of Arizona), Janiel M. Cragun(University of Arizona), Janice L. Cohen(University of Arizona), H.‐H. Sherry Chow(German Cancer Research Center)
Cited by 32
Related Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Non‐erosive reflux disease (NERD) — acid reflux and symptom patterns
|Alimentary Pharmacology & Therapeutics|2003|396
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383
Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
|Scientific Reports|2018|290
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival
|Journal of Laboratory and Clinical Medicine|2003|219